New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Study finds diet contributes to risk of HPV-related cancer

Study finds diet contributes to risk of HPV-related cancer

by Louisiana State UniversityElectron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domainA study conducted by LSU Health New Orleans&
Oncology February 23,2024
Study finds diet contributes to risk of HPV-related cancer

Study finds diet contributes to risk of HPV-related cancer

by Louisiana State UniversityElectron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domainA study conducted by LSU Health New Orleans&
Oncology February 23,2024
Study uncovers how B cells react to skin cancer

Study uncovers how B cells react to skin cancer

by King's College LondonSpatial transcriptomic coupled with high throughput intratumoral antibody repertoire analyses suggest an active but aberrant B cell response.aRepresentativ
Oncology February 23,2024
Study uncovers how B cells react to skin cancer

Study uncovers how B cells react to skin cancer

by King's College LondonSpatial transcriptomic coupled with high throughput intratumoral antibody repertoire analyses suggest an active but aberrant B cell response.aRepresentativ
Oncology February 23,2024
Study reveals how treatment-resistant prostate cancer provides its own hormonal fuel

Study reveals how treatment-resistant prostate cancer provides its own hormonal fuel

by Julia Evangelou Strait,Washington University in St. LouisThin slice of a human prostate tumor. The dark staining throughout reveals the presence of histone acetylation promoting cholesterol p
Oncology February 23,2024
Study reveals how treatment-resistant prostate cancer provides its own hormonal fuel

Study reveals how treatment-resistant prostate cancer provides its own hormonal fuel

by Julia Evangelou Strait,Washington University in St. LouisThin slice of a human prostate tumor. The dark staining throughout reveals the presence of histone acetylation promoting cholesterol p
Oncology February 23,2024
Researchers find capsules surrounding liver metastases of colorectal cancer are a healing response by the liver

Researchers find capsules surrounding liver metastases of colorectal cancer are a healing response by the liver

by Karolinska InstitutetFluorescent protein stains of tumor growing in the liver. Credit: Marco Gerling, Carina StrellA study by researchers from Karolinska Institutet and physicians from Karolin
Oncology February 23,2024
Researchers find capsules surrounding liver metastases of colorectal cancer are a healing response by the liver

Researchers find capsules surrounding liver metastases of colorectal cancer are a healing response by the liver

by Karolinska InstitutetFluorescent protein stains of tumor growing in the liver. Credit: Marco Gerling, Carina StrellA study by researchers from Karolinska Institutet and physicians from Karolin
Oncology February 23,2024
Researchers leverage cell self-destruction to treat brain tumors

Researchers leverage cell self-destruction to treat brain tumors

by University of North Carolina Health CareAn MRI showing glioblastoma pre- and post-operation. Credit: Dominique Higgins, MD, PhDGlioblastoma is the most common type of brain tumor in adults. Th
Oncology February 23,2024
Researchers leverage cell self-destruction to treat brain tumors

Researchers leverage cell self-destruction to treat brain tumors

by University of North Carolina Health CareAn MRI showing glioblastoma pre- and post-operation. Credit: Dominique Higgins, MD, PhDGlioblastoma is the most common type of brain tumor in adults. Th
Oncology February 23,2024
Exercise can increase the number of immune cells in the bloodstream of cancer patients

Exercise can increase the number of immune cells in the bloodstream of cancer patients

by University of TurkuCredit: Unsplash/CC0 Public DomainExercise decreases the risk of cancer and reduces side effects of cancer treatments. In addition, it improves patients' quality of life
Oncology February 23,2024
Exercise can increase the number of immune cells in the bloodstream of cancer patients

Exercise can increase the number of immune cells in the bloodstream of cancer patients

by University of TurkuCredit: Unsplash/CC0 Public DomainExercise decreases the risk of cancer and reduces side effects of cancer treatments. In addition, it improves patients' quality of life
Oncology February 23,2024
Researchers discover the mechanism by which tumor cells become resistant to chemotherapy in colorectal cancer

Researchers discover the mechanism by which tumor cells become resistant to chemotherapy in colorectal cancer

by Institute for Research in Biomedicine (IRB Barcelona)Oxaliplatin accumulation in the tumor microenvironment of a patient with colon cancer 44 days after treatment. Credit: IMIMPlatinum-based c
Oncology February 23,2024
Researchers discover the mechanism by which tumor cells become resistant to chemotherapy in colorectal cancer

Researchers discover the mechanism by which tumor cells become resistant to chemotherapy in colorectal cancer

by Institute for Research in Biomedicine (IRB Barcelona)Oxaliplatin accumulation in the tumor microenvironment of a patient with colon cancer 44 days after treatment. Credit: IMIMPlatinum-based c
Oncology February 23,2024
Researchers invent novel ingestible capsule X-ray dosimeter for real-time radiotherapy monitoring

Researchers invent novel ingestible capsule X-ray dosimeter for real-time radiotherapy monitoring

by National University of SingaporeThe components of the dosimeter fit into an 18mm by 7mm capsule, a common size for many supplements and medicines. Credit: National University of SingaporeGastr
Oncology February 23,2024
Researchers invent novel ingestible capsule X-ray dosimeter for real-time radiotherapy monitoring

Researchers invent novel ingestible capsule X-ray dosimeter for real-time radiotherapy monitoring

by National University of SingaporeThe components of the dosimeter fit into an 18mm by 7mm capsule, a common size for many supplements and medicines. Credit: National University of SingaporeGastr
Oncology February 23,2024
Promising new treatment for deadly pediatric tumors

Promising new treatment for deadly pediatric tumors

by Konstanze Adam, Wilhelm Sander-StiftungA simplified schematic of the DNA damage repair pathways. Below there is the curves showing cell viability in response to the ATR inhibitors (AZD6738 and BAY
Oncology February 23,2024
Promising new treatment for deadly pediatric tumors

Promising new treatment for deadly pediatric tumors

by Konstanze Adam, Wilhelm Sander-StiftungA simplified schematic of the DNA damage repair pathways. Below there is the curves showing cell viability in response to the ATR inhibitors (AZD6738 and BAY
Oncology February 23,2024
Researchers identify genes that cause rare hidden cancer

Researchers identify genes that cause rare hidden cancer

by Garvan Institute of Medical ResearchIHC staining of human sarcoma cells (myxoid liposarcoma). Credit: Garvan Institute of Medical ResearchSeveral genes that cause sarcoma have been identified
Oncology February 23,2024
Researchers identify genes that cause rare hidden cancer

Researchers identify genes that cause rare hidden cancer

by Garvan Institute of Medical ResearchIHC staining of human sarcoma cells (myxoid liposarcoma). Credit: Garvan Institute of Medical ResearchSeveral genes that cause sarcoma have been identified
Oncology February 23,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com